Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Identify research insights to guide ...
MUMBAI, India & HYDERABAD, India--(BUSINESS WIRE)--PopVax, an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics using machine learning-enabled computational ...
Work at the National Institute of Allergy and Infectious Disease’s Integrated Research Facility at Fort Detrick has been ordered to stop by the National Institutes of Health, officials confirmed on ...
Parents across the U.S. are introducing peanut products to their infants earlier than ever, following guidelines that the ...
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Lactiga, a biotech company leading the development of naturally-occurring antibody therapies for inflammatory and immunodeficient conditions, has been awarded a ...
In the early days of the second Trump administration, a directive to pause all public communication from the Department of Health and Human Services created uncertainty and anxiety among biomedical ...
Proposed legislation, should it make its way through Congress, would dismantle the National Institute of Allergy and Infectious Diseases (NIAID) as it currently exists, replacing it with three ...
DARE-HPV is a potential first-in-category treatment for human papillomavirus (HPV)-related cervical disease which could change the treatment paradigm for clinical HPV management Essentially all ...
Growing research suggests the bacteria left behind by the common childhood infection may trick the immune system into attacking both the invader and the body's own cells.
© 2026 TIME USA, LLC. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Service, Privacy Policy (Your Privacy Rights) and Do Not Sell or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results